Diagnostics News and Research

RSS

BioMedReports electronic newsletter releases an article about Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV, and hepatitis testing, today announced the Company is the subject of a cover page story in the prestigious BioMedReports electronic newsletter and portal.

14 Oct 2009

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Smiths Detection today announces the award of a $1m, two-year grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a rapid test for eight micro-organisms that commonly cause burn/wound infections leading to septicemia (blood-poisoning).

14 Oct 2009

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

According to a new report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $12.8 billion in 2008 to $17.8 billion by 2014.

14 Oct 2009

New diagnostic technology to detect breast cancer

"We were ready to start a family when a mammogram revealed an abnormal mass in my left breast," said Staci Sansolo, 34, of New Jersey. A biopsy revealed the mass was not cancer, but a second-round test found another area of concern.

14 Oct 2009

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Smiths Detection today announces the award of a $2.2m, two-year grant from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop a test for multiple types of influenza.

14 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Premier Purchasing Partners awards new agreements for blood bank analyzers

Premier Purchasing Partners, LP, today announced new agreements for blood bank analyzers, reagents, consumables and service have been awarded to Biotest Diagnostics Corporation of Rockaway, N.J.; and Johnson & Johnson Health Care Systems Inc. of Piscataway, N.J., contracting on behalf of Ortho-Clinical Diagnostics, Inc. of Raritan, N.J.

13 Oct 2009

Diagnostics industry in Asia Pacific poised to present more growth opportunities

The global diagnostics industry has witnessed strong growth over the past few years. According to Frost & Sullivan, the diagnostics and monitoring sectors are poised to present more growth opportunities. According to Nitin Naik, Vice President of Frost & Sullivan's Asia Pacific Medical Technologies Division, the diagnostics and monitoring sectors in Asia Pacific are projected to provide more growth opportunities on the basis of the technology spending being channelled in these areas (80 percent).

13 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

Dilon Diagnostics and Philips sign distribution agreement

Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips (NYSE: PHG, AEX: PHI), today announce that they have entered into a distribution agreement. Philips Healthcare will sell and support the Dilon 6800 gamma camera in key European and Middle Eastern markets. The compact camera technology and related products and services are used for the detection of breast cancer as an adjunct to mammography and serve to complement Philips innovative women's health solutions.

12 Oct 2009

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

12 Oct 2009

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

A new technique in Magnetic Resonance Imaging dubbed "Hyper-SAGE" has the potential to detect ultra low concentrations of clincal targets, such as lung and other cancers. Development of Hyper-SAGE was led by one of the world's foremost authorities on MRI technology, Alexander Pines, a chemist who holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Berkeley.

12 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Aperio Technologies, Inc., a global leader in digital pathology for the healthcare and life sciences industry is pleased to announce that SecondSlide™, its newly launched digital slide sharing service for pathology, has been incorporated as one of the vendor solutions in the College of American Pathologists (CAP) prototype of the Diagnostic Work Station (DWS), a collaborative and heterogeneous vendor-neutral environment.

9 Oct 2009

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it has entered into an exclusive 5-year marketing and distribution agreement with Grifols USA, LLC.

9 Oct 2009

Study finds BSGI to be a cost-effective breast diagnostic imaging modality

Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique with comparable sensitivity to breast magnetic resonance imaging (MRI) for detecting breast carcinoma when used in pre-surgical planning for patients with known cancer diagnoses and is substantially less expensive than MRI, according to findings presented today at the American Society of Clinical Oncology Breast Cancer Symposium in San Francisco, California.

9 Oct 2009

Adnavance Technologies to present its DNA direct detection technology at the AdvaMed 2009

Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that Randy White, Ph.D. chief executive officer, will present initial data supporting direct detection of DNA targets in human clinical samples during company presentations.

8 Oct 2009

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

8 Oct 2009

New research report outlines growth prospects of Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.

8 Oct 2009

Diagnostics News and Research

BioMedReports electronic newsletter releases an article about Biomagnetics Diagnostics

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

New diagnostic technology to detect breast cancer

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Johnson & Johnson announces financial results for the third quarter of 2009

Premier Purchasing Partners awards new agreements for blood bank analyzers

Diagnostics industry in Asia Pacific poised to present more growth opportunities

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Federal stimulus funds for comparative-effectiveness research in cancer

Dilon Diagnostics and Philips sign distribution agreement

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

Hyper-SAGE with MRI sensitivity, a promising tool for in vivo diagnostics and molecular imaging

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

Study finds BSGI to be a cost-effective breast diagnostic imaging modality

Adnavance Technologies to present its DNA direct detection technology at the AdvaMed 2009

Development of lab-on-chip system for breast cancer detection and therapy

New research report outlines growth prospects of Biomagnetics Diagnostics

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News